Researchers in Dr. Karl Deisseroth's lab have developed a selective approach to treat anxiety. Anxiety is characterized by several features that are coordinately regulated by diverse neuronal system outputs.
Researchers in Prof. Karl Diesseroth's laboratory have discovered a Dopamine receptor type 2 specific promoter (D2SP) that can be used to transfect, identify and isolate Dopamine R2 (D2R)-expressing cells.
The Bronte-Stewart lab has designed an algorithm for calculating neural activity burst duration to better manage closed loop deep brain stimulation in patients with Parkinson's disease.
Stanford researchers have created a portable, wearable device for long-term nystagmus tracking to better diagnose episodic vertigo. Current methods utilize head goggles in video nystagmography to monitor eye movement while the patient is in a clinical setting.
Neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) have been characterized by the expansion of the GGGGCC hexanucleotide repeat within the non-coding region of the human chromosome 9 open reading frame 72 (C9ORF72) gene.
Stanford researchers in the laboratory of Dr. Daria Mochly-Rosen have developed novel small molecules for modulating ALDH2 (mitochondrial aldehyde dehydrogenase-2).
Stanford researchers have developed a safe and effective system that enables neurofeedback training in combination with neuromodulation for the treatment of brain disorders characterized by abnormal neuronal synchrony and synaptic connectivity.
Stanford researchers in the Camarillo Lab have patented a model-less, robotic position-control technique that regulates force. The controller simultaneously controls position and applied forces of the manipulator as it moves through a workspace, without requiring a model.
Stanford researchers have discovered that dietary metabolites, specifically alpha-ketoglutarate, are able to delay retinal degeneration to treat blinding retinal diseases regardless of the type of retinal condition.
Stanford researchers have identified lipid droplet accumulating microglia (LAM) in aging brains, proposing that these microglia play a role in neurodegenerative disease.
The Hong Neurotechnology Lab at Stanford University developed ultrasound-activated nanoscopic light emitters (mechanoluminescent nanoparticles) that are delivered via the blood stream, unlike conventional optogenetics approaches that require invasive fiber optic implants.